194 related articles for article (PubMed ID: 6321649)
1. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
[TBL] [Abstract][Full Text] [Related]
2. Afferent influences on striatal development in organotypic cocultures.
Snyder-Keller A; Tseng KY; Lyng GD; Graber DJ; O'Donnell P
Synapse; 2008 Jul; 62(7):487-500. PubMed ID: 18435420
[TBL] [Abstract][Full Text] [Related]
3. Prenatal inflammatory effects on nigrostriatal development in organotypic cultures.
Snyder-Keller A; Stark PF
Brain Res; 2008 Oct; 1233():160-7. PubMed ID: 18710655
[TBL] [Abstract][Full Text] [Related]
4. A mouse juvenile or adult slice with preserved functional nigro-striatal dopaminergic neurons.
Ammari R; Lopez C; Fiorentino H; Gonon F; Hammond C
Neuroscience; 2009 Mar; 159(1):3-6. PubMed ID: 19032976
[TBL] [Abstract][Full Text] [Related]
5. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
6. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
7. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H
Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931
[TBL] [Abstract][Full Text] [Related]
8. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
9. Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate.
Sladek JR; Bjugstad KB; Collier TJ; Bundock EA; Blanchard BC; Elsworth JD; Roth RH; Redmond DE
Cell Transplant; 2008; 17(4):427-44. PubMed ID: 18522245
[TBL] [Abstract][Full Text] [Related]
10. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
11. A type of aspiny neuron in the rat neostriatum accumulates [3H]gamma-aminobutyric acid: combination of Golgi-staining, autoradiography, and electron microscopy.
Bolam JP; Clarke DJ; Smith AD; Somogyi P
J Comp Neurol; 1983 Jan; 213(2):121-34. PubMed ID: 6841665
[TBL] [Abstract][Full Text] [Related]
12. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
Toide K; Unemi N; Segawa T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic development of prenatal ventral mesencephalon and striatum in organotypic co-cultures.
Lyng GD; Snyder-Keller A; Seegal RF
Brain Res; 2007 Feb; 1133(1):1-9. PubMed ID: 17196555
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
[TBL] [Abstract][Full Text] [Related]
15. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
16. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
Lavoute C; Weiss M; Rostain JC
Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide co-release with GABA may explain functional non-monotonic uncertainty responses in dopamine neurons.
Tan CO; Bullock D
Neurosci Lett; 2008 Jan; 430(3):218-23. PubMed ID: 18053647
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
19. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
Ugrumov MV; Melnikova VI; Lavrentyeva AV; Kudrin VS; Rayevsky KS
Neuroscience; 2004; 124(3):629-35. PubMed ID: 14980733
[TBL] [Abstract][Full Text] [Related]
20. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.
Deng YP; Lei WL; Reiner A
J Chem Neuroanat; 2006 Dec; 32(2-4):101-16. PubMed ID: 16914290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
